MEDICA LABMED FORUM presents innovations from the world of laboratory medicine

Sept. 6, 2022
Presenting the newest trends in in-vitro diagnostics for discriminating stages of disease, monitoring the course of disease and therapy, and preventing diseases.

In spite of, or maybe especially because of the COVID-19 pandemic, the MEDICA LABMED FORUM has been enjoying growing recognition within both academia and the industry. During MEDICA 2022 (November 14-17), the newest scientific findings from across the broad spectrum of diagnostic medicine will be presented again in Hall 1. As part of the program by the specialist forum for laboratory medicine, renowned experts will be holding highly up-to-date lectures here on stage. 

After having taken place on a completely digital platform due to the pandemic in 2020, the MEDICA LABMED FORUM returned last year as an in-person meeting-point for international guests. The two scientific organizers, Prof. Dr. med.  Georg Hoffmann and Prof. Dr med. Stefan Holdenrieder, both laboratory doctors at the institute for laboratory medicine at the German Heart Centre of the Technical University of Munich, have put together a total of eight sessions for this year and created an inviting, multi-faceted program about notable trends within in-vitro diagnostics (IVD). 

The motto of the opening day will be "Regulations and quality." The second day of the event is dedicated to short lectures and interactive stage discussions about the newest trends in laboratory medicine. On November 16, recently discovered biomarkers take central stage. The closing day on November 17 will showcase innovative developments within the life sciences. 

MEDICA release